Skip to content

Effects of diode laser with and without a desensitizing agent in the treatment of dentinal hypersensitivity

Comparative Evaluation of diode laser with and without a desensitizing agent in the treatment of dentinal hypersensitivity : A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041381
Enrollment
33
Registered
2022-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dentinal Hypersensitivity: Group I-After air drying for 3 seconds, and isolation Diode Laser with a wavelength of 810nm Class4 type B will be irradiated in non contact ,, continuous mod

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are cooperative, motivated and willing to participate in the study will be included. 2. Patients who will be having sensitive teeth that show abrasion, erosion or gingival recession with exposure of cervical dentin. 3. Patients having good systemic health with clinically elicitable dentinal hypersensitivity who will be reliable in their response to test measurements. 4. Patients who will be willing and available for recall follow ups. 5. Patients with no known allergies to commercial dental products. 6. History of no use of desensitizing toothpaste or mouthwash past 3 months. 7. Patients who have not received any professional desensitizing therapy for dentinal hypersensitivity in the past 3 months. 8. Patients who will be having minimum 1 and maximum 32 hypersensitive teeth will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Patients having deep dental caries or large restorations on the selected hypersensitive teeth. 2. Patients who will be having cracked or chipped teeth with hypersensitivity. 3. Patients with cervical restorations or premature contacts on the hypersensitive teeth. 4. Patients who will be having chronic disease with daily pain episodes, and on any analgesics / antiâ??inflammatory, anticonvulsive, anti-histaminic, tranquilizing or sedative medication drugs in the last 72 hours. 5. Patients who are lactating or are pregnant women . 6. Patients with any cardio-circulatory disease or having cardio pacemaker. 7. Patients with the habit of smoking or alcohol intake. 8. Patients who will not consent to participate or to attend the follow up recall appointments. 9. Excessive dietary or environmental exposure to acids.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be mean pain reduction The discomfort / pain will be recorded by VISUAL ANALOG SCALE (VAS) and VERBAL RATING SCALE(VRS) Tactile test and air blast stimulus recordings will be assessed at baseline- before treatment , 15 minutes after treatment, 7th day,14th day,30th day and 90th day after treatment. Timepoint: Primary outcome will be mean pain reduction The discomfort / pain will be recorded by VISUAL ANALOG SCALE (VAS) and VERBAL RATING SCALE(VRS)Tactile test and air blast stimulus recordings will be assessed at baseline- before treatment , 15 minutes after treatment, 7th day,14th day,30th day and 90th day after treatment.

Secondary

MeasureTime frame
Plaque index, Gingival indexTimepoint: Assessment will be done at baseline i.e. before treatment, at 7th day , 14th day , 30th day and on 90th day after treatment

Countries

India

Contacts

Public ContactDr Shalini Gugnani

J.N.Kapoor DAV (c) Dental college Yamuna Nagar , Haryana

drshalinigugnani@gmail.com7988640565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026